These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22244977)

  • 1. A broad-spectrum matrix metalloproteinase inhibitor prevents hemorrhagic complications induced by tissue plasminogen activator in mice.
    Mishiro K; Ishiguro M; Suzuki Y; Tsuruma K; Shimazawa M; Hara H
    Neuroscience; 2012 Mar; 205():39-48. PubMed ID: 22244977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinases inhibition provides neuroprotection against hypoxia-ischemia in the developing brain.
    Chen W; Hartman R; Ayer R; Marcantonio S; Kamper J; Tang J; Zhang JH
    J Neurochem; 2009 Nov; 111(3):726-36. PubMed ID: 19712057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Rho kinase (ROCK) inhibitor, fasudil, prevents matrix metalloproteinase-9-related hemorrhagic transformation in mice treated with tissue plasminogen activator.
    Ishiguro M; Kawasaki K; Suzuki Y; Ishizuka F; Mishiro K; Egashira Y; Ikegaki I; Tsuruma K; Shimazawa M; Yoshimura S; Iwama T; Hara H
    Neuroscience; 2012 Sep; 220():302-12. PubMed ID: 22710066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant tissue plasminogen activator induces blood-brain barrier breakdown by a matrix metalloproteinase-9-independent pathway after transient focal cerebral ischemia in mouse.
    Copin JC; Bengualid DJ; Da Silva RF; Kargiotis O; Schaller K; Gasche Y
    Eur J Neurosci; 2011 Oct; 34(7):1085-92. PubMed ID: 21895804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracerebral transplantation of bone marrow stromal cells ameliorates tissue plasminogen activator-induced brain damage after cerebral ischemia in mice detected by in vivo and ex vivo optical imaging.
    Liu N; Deguchi K; Yamashita T; Liu W; Ikeda Y; Abe K
    J Neurosci Res; 2012 Nov; 90(11):2086-93. PubMed ID: 22791305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progesterone attenuates hemorrhagic transformation after delayed tPA treatment in an experimental model of stroke in rats: involvement of the VEGF-MMP pathway.
    Won S; Lee JH; Wali B; Stein DG; Sayeed I
    J Cereb Blood Flow Metab; 2014 Jan; 34(1):72-80. PubMed ID: 24045404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-β1 prevents blood-brain barrier damage and hemorrhagic transformation after thrombolysis in rats.
    Cai Y; Liu X; Chen W; Wang Z; Xu G; Zeng Y; Ma Y
    Exp Neurol; 2015 Apr; 266():120-6. PubMed ID: 25708985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of tPA-induced hemorrhagic transformation involves adenosine A2b receptor activation after cerebral ischemia.
    Li Q; Han X; Lan X; Hong X; Li Q; Gao Y; Luo T; Yang Q; Koehler RC; Zhai Y; Zhou J; Wang J
    Neurobiol Dis; 2017 Dec; 108():173-182. PubMed ID: 28830843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melatonin inhibits postischemic matrix metalloproteinase-9 (MMP-9) activation via dual modulation of plasminogen/plasmin system and endogenous MMP inhibitor in mice subjected to transient focal cerebral ischemia.
    Tai SH; Chen HY; Lee EJ; Chen TY; Lin HW; Hung YC; Huang SY; Chen YH; Lee WT; Wu TS
    J Pineal Res; 2010 Nov; 49(4):332-41. PubMed ID: 20663046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IMM-H004 prevents toxicity induced by delayed treatment of tPA in a rat model of focal cerebral ischemia involving PKA-and PI3K-dependent Akt activation.
    Zuo W; Chen J; Zhang S; Tang J; Liu H; Zhang D; Chen N
    Eur J Neurosci; 2014 Jun; 39(12):2107-18. PubMed ID: 24649933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YiQiFuMai Lyophilized Injection ameliorates tPA-induced hemorrhagic transformation by inhibiting cytoskeletal rearrangement associated with ROCK1 and NF-κB signaling pathways.
    Pan XW; Wang MJ; Gong SS; Sun MH; Wang Y; Zhang YY; Li F; Yu BY; Kou JP
    J Ethnopharmacol; 2020 Nov; 262():113161. PubMed ID: 32730882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microglial low-density lipoprotein receptor-related protein 1 mediates the effect of tissue-type plasminogen activator on matrix metalloproteinase-9 activity in the ischemic brain.
    Zhang C; An J; Haile WB; Echeverry R; Strickland DK; Yepes M
    J Cereb Blood Flow Metab; 2009 Dec; 29(12):1946-54. PubMed ID: 19672275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue plasminogen activator prevents restoration of tight junction proteins through upregulation of angiopoietin-2.
    Mishiro K; Ishiguro M; Suzuki Y; Tsuruma K; Shimazawa M; Hara H
    Curr Neurovasc Res; 2013 Feb; 10(1):39-48. PubMed ID: 23151074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-density lipoprotein-based therapy reduces the hemorrhagic complications associated with tissue plasminogen activator treatment in experimental stroke.
    Lapergue B; Dang BQ; Desilles JP; Ortiz-Munoz G; Delbosc S; Loyau S; Louedec L; Couraud PO; Mazighi M; Michel JB; Meilhac O; Amarenco P
    Stroke; 2013 Mar; 44(3):699-707. PubMed ID: 23422087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NAD replenishment with nicotinamide mononucleotide protects blood-brain barrier integrity and attenuates delayed tissue plasminogen activator-induced haemorrhagic transformation after cerebral ischaemia.
    Wei CC; Kong YY; Hua X; Li GQ; Zheng SL; Cheng MH; Wang P; Miao CY
    Br J Pharmacol; 2017 Nov; 174(21):3823-3836. PubMed ID: 28812311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ascorbic Acid Reduces the Adverse Effects of Delayed Administration of Tissue Plasminogen Activator in a Rat Stroke Model.
    Allahtavakoli M; Amin F; Esmaeeli-Nadimi A; Shamsizadeh A; Kazemi-Arababadi M; Kennedy D
    Basic Clin Pharmacol Toxicol; 2015 Nov; 117(5):335-9. PubMed ID: 25899606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrogen Sulfide Attenuates Tissue Plasminogen Activator-Induced Cerebral Hemorrhage Following Experimental Stroke.
    Liu H; Wang Y; Xiao Y; Hua Z; Cheng J; Jia J
    Transl Stroke Res; 2016 Jun; 7(3):209-19. PubMed ID: 27018013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats.
    Sumii T; Lo EH
    Stroke; 2002 Mar; 33(3):831-6. PubMed ID: 11872911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinase activation and blood-brain barrier breakdown following thrombolysis.
    Kelly MA; Shuaib A; Todd KG
    Exp Neurol; 2006 Jul; 200(1):38-49. PubMed ID: 16624294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat.
    Yang Y; Estrada EY; Thompson JF; Liu W; Rosenberg GA
    J Cereb Blood Flow Metab; 2007 Apr; 27(4):697-709. PubMed ID: 16850029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.